The genetic or pharmacologic inhibition of HIPK2 attenuates the VAN-induced progression of AKI to CKD and prevents renal fibrosis, as evidenced by improved renal function, reduced tubular damage, and attenuated cell apoptosis [83]. This evidence concerns the gene HIPK2 and acute kidney injury.